Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer
Eun Kyung Cho, Ji-Young Park, Kyung Hee Lee, Hong Suk Song, Young Joo Min, Yeul Hong Kim, Jin Hyoung Kang
Dive into the research topics of 'Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer'. Together they form a unique fingerprint.